Previous studies have shown that 5–10% of patients with T2DM exhibit autoantibodies against the islet antigen glutamic acid decarboxylase, 65 kDa isoform, (GAD), one of the well-recognized markers of islet cell autoimmunity in Type 1 diabetes (T1DM). This evidence concerns the gene GAD1 and type 2 diabetes mellitus.